Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 27, 2017

DrugPatentWatch Database Preview

Oxaliplatin - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for oxaliplatin and what is the scope of freedom to operate?

Oxaliplatin
is the generic ingredient in two branded drugs marketed by Actavis Totowa, Fresenius Kabi Oncol, Sandoz Inc, Hospira Worldwide, Hospira Inc, Qilu Pharm Co Ltd, Sandoz, Sun Pharma Global, Fresenius Kabi Usa, Cipla Ltd, Gland Pharma Ltd, Mylan Labs Ltd, Sanofi Aventis Us, Teva Pharms, Jiangsu Hengrui Med, and Accord Hlthcare, and is included in twenty-three NDAs. There are two patents protecting this compound and four Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Oxaliplatin has five patent family members in four countries.

There are twenty-six drug master file entries for oxaliplatin. Eighteen suppliers are listed for this compound. There are six tentative approvals for this compound.

Summary for Generic Name: oxaliplatin

Tradenames:2
Patents:2
Applicants:16
NDAs:23
Drug Master File Entries: see list26
Suppliers / Packagers: see list18
Clinical Trials: see list496
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:oxaliplatin at DailyMed

Pharmacology for Ingredient: oxaliplatin

Tentative approvals for OXALIPLATIN

Applicant Application No. Form Dosage
► Subscribe► SubscribeINJECTABLE; INJECTION5MG/ML
► Subscribe► SubscribeINJECTABLE; INJECTION5MG/ML
► Subscribe► SubscribeINJECTABLE; IV (INFUSION)200MG/40ML
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us
ELOXATIN
oxaliplatin
INJECTABLE;IV (INFUSION)021492-001Aug 9, 2002DISCNYesNo5,420,319*PED► SubscribeY► Subscribe
Fresenius Kabi Usa
OXALIPLATIN
oxaliplatin
INJECTABLE;IV (INFUSION)090030-002Jan 31, 2017APRXNoNo► Subscribe► Subscribe
Sanofi Aventis Us
ELOXATIN
oxaliplatin
INJECTABLE;IV (INFUSION)021492-002Aug 9, 2002DISCNYesNo5,420,319*PED► SubscribeY► Subscribe
Qilu Pharm Co Ltd
OXALIPLATIN
oxaliplatin
INJECTABLE;IV (INFUSION)204368-002Jun 7, 2016APRXNoNo► Subscribe► Subscribe
Accord Hlthcare
OXALIPLATIN
oxaliplatin
INJECTABLE;IV (INFUSION)207474-002Mar 21, 2017APRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Formulary management
  • Identify first generic entrants
  • Uncover prior art in abandoned patent applications and expired patents

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot